Cover image of the article: The Significance of Bladder Cancer in Iran

Image Credit:Int J Cancer Manag

The Significance of Bladder Cancer in Iran

Authors

Safa NajafiSafa Najafi ORCID1, 2, 3, Sirous Rafiei AslSirous Rafiei Asl ORCID4, 5, 6,*
How to Cite:Najafi S, Rafiei Asl S. The Significance of Bladder Cancer in Iran. Int J Cancer Manag. 2026;19(1):e175540. doi: https://doi.org/10.5812/ijcm-175540

Recommendations for Future Research

Given the importance of this subject, the following studies are recommended to complement and deepen existing knowledge of bladder cancer:
1. Conduct large-scale cohort studies with long-term follow-up to confirm the causal relationships between identified risk factors, particularly occupational exposure and opium use, and the incidence of bladder cancer.
2. Conduct studies involving quantitative exposure assessment through measurement of carcinogen metabolites, such as aromatic amines, in the blood or urine of workers in high-risk industries.
3. Investigate the association between risk factors, including specific concentrations of carcinogens in the workplace, and the incidence of specific histopathological subtypes of bladder cancer.
4. Design and evaluate the effectiveness of targeted screening programs for workers in high-risk occupations and individuals with a positive family history.
5. Focus on research into urinary biomarkers, conduct cost-effectiveness analyses, and precisely define target groups.
Conducting such research could lead to the development of strategies for the prevention and early detection of bladder cancer and more targeted treatment at the national level.

Acknowledgments

Footnotes

  • AI Use Disclosure:The authors declare that no generative AI tools were used to create this article.

  • Authors' Contribution:Sirous Rafiei Asl performed study conceptualization and design, data analysis and interpretation, critical revision of the manuscript, and study supervision; Safa Najafi collected the data and drafted the manuscript.

  • Conflict of Interests Statement:The authors declare no conflicts of interest. Sirous Rafiei Asl is a faculty member at Ahvaz Jundishapur University of Medical Sciences and a reviewer for this journal.

  • Funding/Support:The authors received no funding for this study.

References

  • 1.
    Najafi S, Askarykia J, Rafiei Asl S, Sarkarian M. Risk factors associated with bladder cancer based on pathological results: A case–control study in Ahvaz. Trans Res Urol. 2026. e245301. https://doi.org/10.22034/tru.2026.580249.1337.
  • 2.
    Yashaswini C. Epidemiology and risk factors of bladder cancer. In: Prajapati BG, Kapoor DU, AlAsmari AF, editors. Bladder Cancer Breakthroughs. Academic Press; 2026. p. 1-12.
  • 3.
    Cumberbatch MGK, Jubber I, Black PC, Esperto F, Figueroa JD, Kamat AM, et al. Epidemiology of bladder cancer: A systematic review and contemporary update of risk factors in 2018. Eur Urol. 2018;74(6):784-795. [PubMed ID: 30268659]. https://doi.org/10.1016/j.eururo.2018.09.001.
  • 4.
    Hosseini AS, Jalali SM, Shateri Z, Shoja M, Rajabzadeh-Dehkordi M, Makhtoomi M, et al. The association between digestion-resistant and bioactive peptide content of dairy products and bladder cancer: A case-control study. J Health Popul Nutr. 2025;44(1):336. [PubMed ID: 41029398]. [PubMed Central ID: PMC12486994]. https://doi.org/10.1186/s41043-025-01071-2.
  • 5.
    Abdolahinia Z, Mirzaee M, Pakmanesh H, Bazrafshan A, Shafiei Bafti M, Shahesmaeili A. Prevalence of bladder cancer in the Kerman Province, Southeastern Iran, using the complete prevalence method. Journal of Occupational Health and Epidemiology. 2022;11(3):180-186. https://doi.org/10.61186/johe.11.3.180.
  • 6.
    Hadji M, Rashidian H, Marzban M, Naghibzadeh-Tahami A, Gholipour M, Mohebbi E, et al. Opium use and risk of bladder cancer: A multi-centre case-referent study in Iran. Int J Epidemiol. 2022;51(3):830-838. [PubMed ID: 35244716]. [PubMed Central ID: PMC9189939]. https://doi.org/10.1093/ije/dyac031.
  • 7.
    Rashidian H, Haghdoost AA, Daroudi R, Raadabadi M, Ebadzadeh MR, Zendehdel K. Estimating the prevalence of bladder cancer by stage in Iran as a developing country. Med J Islam Repub Iran. 2022;36:37. [PubMed ID: 36128281]. [PubMed Central ID: PMC9448492]. https://doi.org/10.47176/mjiri.36.37.
  • 8.
    Nowroozi MR, Amini E, Farkhani EM, Nowroozi A, Ayati M, Momeni SA, et al. National and subnational incidence trend of bladder cancer in Iran: Report of a 12-year period. Int J Cancer Manag. 2023;16(1). e127005. https://doi.org/10.5812/ijcm-127005.
  • 9.
    Sadeghi A, Nouri F, Dehdari Ebrahimi N, Taherifard E, Soltani M, Williams SB, et al. Bladder cancer in the United States: National trends and state-level patterns from Global Burden of Disease (GBD) study, 1980-2021. medRxiv. 2026. https://doi.org/10.64898/2026.07.11.26357810.
  • 10.
    Joyce DD, Sharma V, Williams SB. Cost-effectiveness and economic impact of bladder cancer management: An updated review of the literature. Pharmacoeconomics. 2023;41(7):751-769. [PubMed ID: 37088844]. https://doi.org/10.1007/s40273-023-01273-8.

Copyright

Copyright © 2026, Najafi and Rafiei Asl. This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

23
Dec
2015
Characteristics of Patients With Transitional Cell Carcinoma of the Urinary Bladder in Kermanshah Province, Iran

Characteristics of Patients With Transitional Cell Carcinoma of the Urinary Bladder in Kermanshah Province, Iran

Mehrdad Payandeh,
Masoud Sadeghi,
Edris Sadeghi

Payandeh M, Sadeghi M, Sadeghi E. Characteristics of Patients With Transitional Cell Carcinoma of the Urinary Bladder in Kermanshah Province, Iran. Int J Cancer Manag. 2015;8(6):e4038. doi: https://doi.org/10.17795/ijcp-4038

16
Oct
2019
Cancers of Urinary System; Prevalence, Demographic

Cancers of Urinary System; Prevalence, Demographic

Zahra Tolou Ghamari

Tolou Ghamari Z. Cancers of Urinary System; Prevalence, Demographic. Jundishapur J Chronic Dis Care. 2019;8(4):e95732. doi: https://doi.org/10.5812/jjcdc.95732

21
Jun
2023
National and Subnational Incidence Trend of Bladder Cancer in Iran: Report of a 12-Year Period

National and Subnational Incidence Trend of Bladder Cancer in Iran: Report of a 12-Year Period

Mohammad Reza Nowroozi,
Erfan Amini,
Ehsan Mosa Farkhani,
Ali Nowroozi,
Mohsen Ayati,
Seyed Ali Momeni
,et al.

Nowroozi MR, Amini E, Farkhani EM, Nowroozi A, Ayati M, et al. National and Subnational Incidence Trend of Bladder Cancer in Iran: Report of a 12-Year Period. Int J Cancer Manag. 2023;16(1):e127005. doi: https://doi.org/10.5812/ijcm-127005

18
Feb
2017
Bladder Cancer in Iran: Geographical Distribution and Risk Factors

Bladder Cancer in Iran: Geographical Distribution and Risk Factors

Tohid Jafari-Koshki,
Shahram Arsang-Jang,
Behzad Mahaki

Jafari-Koshki T, Arsang-Jang S, Mahaki B. Bladder Cancer in Iran: Geographical Distribution and Risk Factors. Int J Cancer Manag. 2017;10(2):e5610. doi: https://doi.org/10.5812/ijcp.5610

30
Apr
2018
Survival Rate of Patients with Bladder Cancer in Yazd, Central Province of Iran

Survival Rate of Patients with Bladder Cancer in Yazd, Central Province of Iran

Hassan-Ali Vahedian-Ardakani,
Mansour Moghimi,
Mohammad Shayestehpour,
Masoud Doosti,
Fatemeh Alimohammadi

Vahedian-Ardakani H, Moghimi M, Shayestehpour M, Doosti M, Alimohammadi F. Survival Rate of Patients with Bladder Cancer in Yazd, Central Province of Iran. Int J Cancer Manag. 2018;11(5):e61436. doi: https://doi.org/10.5812/ijcm.61436

More by these authors

Safa NajafiPubMedScholar
Sirous Rafiei AslPubMedScholar